Correlation Between Vincerx Pharma and Vanda Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Vanda Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Vanda Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Vanda Pharmaceuticals, you can compare the effects of market volatilities on Vincerx Pharma and Vanda Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Vanda Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Vanda Pharmaceuticals.
Diversification Opportunities for Vincerx Pharma and Vanda Pharmaceuticals
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vincerx and Vanda is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Vanda Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanda Pharmaceuticals and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Vanda Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanda Pharmaceuticals has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Vanda Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Vanda Pharmaceuticals
Given the investment horizon of 90 days Vincerx Pharma is expected to generate 2.36 times more return on investment than Vanda Pharmaceuticals. However, Vincerx Pharma is 2.36 times more volatile than Vanda Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Vanda Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest 63.00 in Vincerx Pharma on September 12, 2024 and sell it today you would lose (41.50) from holding Vincerx Pharma or give up 65.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vincerx Pharma vs. Vanda Pharmaceuticals
Performance |
| Timeline |
| Vincerx Pharma |
| Vanda Pharmaceuticals |
Vincerx Pharma and Vanda Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma and Vanda Pharmaceuticals
The main advantage of trading using opposite Vincerx Pharma and Vanda Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Vanda Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanda Pharmaceuticals will offset losses from the drop in Vanda Pharmaceuticals' long position.| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
| Vanda Pharmaceuticals vs. Biomarin Pharmaceutical | Vanda Pharmaceuticals vs. Vaxcyte | Vanda Pharmaceuticals vs. Liquidia Technologies | Vanda Pharmaceuticals vs. Legend Biotech Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |